Bram Lancee’s book Immigrant Performance in the Labour Market: Bonding and Bridging Social Capital, published by Amsterdam University Press, is available open access at OAPEN Open Access Publishing in European Networks.
Lancee – whose academic interests include social capital and social participation, inequality, ethnic minorities and the labour market, attitudes towards immigration and ethnic diversity – is researcher both at the UvA (post-doc) and at the WZB Wissenschaftszentrum Berlin für Sozialforschung (Humboldt fellow). The present publication focuses on the concept (& theory) of social capital and its role with regard to immigrants’ integration and achievements in the labour market. The Netherlands and Germany are taken as case studies.
Olga Sezneva is Assistant Professor of Sociology at the UvA. Her academic interests include migration, urban studies, qualitative methods of research and cultural sociology. It is to the latter that her research activities on intellectual property and global media markets belong.
Sezneva’s article The pirates of Nevskii Prospekt: Intellectual property, piracy and institutional diffusion in Russia, lately published in the interdisciplinary journal Poetics, online available through the UvA-library, focuses on the Russian case study earlier addressed by Sezneva in her contribution to Media Piracy in Emerging Economies, a report published in 2011 by the SSRC Social Science Research Council, an independent, nonprofit international organization promoting innovative research in the social sciences.
When phrase searching the new UvA-library search engine for “intellectual property”, the sheer variety of contexts and issues at stake with this concept is evident even when limiting the results only to the books available at the Bushuis library: from Chinese counterfeit goods to hip-hop artists, and from indigenous people to HIV/AIDS drugs in developing countries, this latter still being a controversial topic more than ten years after Nelson Mandela’s denouncing the price policy of pharmaceutical companies for such drugs.